Sign In
Buy SYRS
Syros Pharmaceuticals Stock Insider Power
Based on the 100 latest insides trades, we have calculated the insider power to be positive at 28.21. In total, the insiders bought 1.07M and sold 1.21M SYRS shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.
Insider Power
|
28.21 |
| ● Buy | 1.07M shares |
| ● Sell | 1.21M shares |
|
74% Buy Activity
Weak Negative Correlation
|
|
Historical Insider Trades
| Date | Type | Person | Role | Amount |
|---|---|---|---|---|
|
Dec 02, 2024 Sell |
Simonian Nancy A Director |
37 070 Value: $10.0K |
||
|
Dec 02, 2024 Sell |
Simonian Nancy A Director |
37 070 Value: $10.0K |
||
|
Nov 25, 2024 Sell |
Simonian Nancy A Director |
134 713 Value: $35.7K |
||
|
Nov 25, 2024 Sell |
Simonian Nancy A Director |
134 713 Value: $35.7K |
||
|
Nov 19, 2024 Sell |
Quirk Gerald E Chief Legal & Compliance Offic |
46 657 Value: $10.3K |
||
|
Nov 19, 2024 Sell |
Quirk Gerald E Chief Legal & Compliance Offic |
46 657 Value: $10.3K |
||
|
Nov 18, 2024 Sell |
Stephens Kristin Chief Development Officer |
36 133 Value: $8K |
||
|
Nov 18, 2024 Sell |
Roth David Chief Medical Officer |
12 099 Value: $2K |
||
|
Nov 18, 2024 Sell |
Chee Conley President & CEO |
134 797 Value: $26.9K |
||
|
Nov 18, 2024 Sell |
Haas Jason Chief Financial Officer |
137 803 Value: $29.0K |
||
|
Nov 18, 2024 Sell |
Haas Jason Chief Financial Officer |
137 803 Value: $29.0K |
||
|
Nov 18, 2024 Sell |
Chee Conley President & CEO |
134 797 Value: $26.9K |
||
|
Nov 18, 2024 Sell |
Roth David Chief Medical Officer |
12 099 Value: $2K |
||
|
Nov 18, 2024 Sell |
Stephens Kristin Chief Development Officer |
36 133 Value: $8K |
||
|
Oct 31, 2024 Buy |
Simonian Nancy A Director |
40 125 Value: $101.1K |
||
|
Oct 31, 2024 Buy |
Simonian Nancy A Director |
40 125 Value: $101.1K |
||
|
Oct 31, 2024 Buy |
Roth David Chief Medical Officer |
18 875 Value: $47.6K |
||
|
Oct 31, 2024 Sell |
Roth David Chief Medical Officer |
6 776 Value: $14.2K |
||
|
Oct 31, 2024 Buy |
Roth David Chief Medical Officer |
18 875 Value: $47.6K |
||
|
Oct 31, 2024 Buy |
Haas Jason Chief Financial Officer |
18 875 Value: $47.6K |
||
|
Oct 31, 2024 Sell |
Haas Jason Chief Financial Officer |
5 624 Value: $11.8K |
||
|
Oct 31, 2024 Buy |
Haas Jason Chief Financial Officer |
18 875 Value: $47.6K |
||
|
Oct 31, 2024 Buy |
Chee Conley President & CEO |
17 000 Value: $42.8K |
||
|
Oct 31, 2024 Sell |
Chee Conley President & CEO |
8 707 Value: $18.2K |
||
|
Oct 31, 2024 Buy |
Chee Conley President & CEO |
17 000 Value: $42.8K |
About Insider Power
Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.
It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.
While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.
* October 6th, 2025 - Tested on 5562 stocks
